Clinical Trials
8 trialsNCT07309276 2026-05-18
A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer
Shanghai Junshi Bioscience Co., Ltd.
Phase 2 Recruiting
NCT07367529 2026-05-05
A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2 Recruiting
NCT06928922 2026-01-13
Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1 Recruiting
NCT07229599 2025-11-17
A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 1/2 Recruiting
NCT06945523 2025-06-04
Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd
Phase 1 Recruiting
NCT06992583 2025-05-28
Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd
Phase 1 Recruiting
NCT06903117 2025-04-03
Anti-CEA CAR-T for Advanced CEA-Positive Lung Carcinoma
Chongqing Precision Biotech Co., Ltd
Phase 1 Recruiting
NCT06768151 2025-01-10
A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd
Phase 1 Recruiting